BOSTON BUSINESS JOURNAL | As the threat posed by drug-resistant bacteria continues to grow, the companies striving to develop antibiotics remain notoriously underfunded.
BOSTON BUSINESS JOURNAL | As the threat posed by drug-resistant bacteria continues to grow, the companies striving to develop antibiotics remain notoriously underfunded.